1-3 of 3
William G. Hawkins
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer

Available to Purchase
C. Alston James, John M. Baer, Chong Zou, Usman Y. Panni, Brett L. Knolhoff, Graham D. Hogg, Natalie L. Kingston, Liang-I. Kang, Varintra E. Lander, Jingqin Luo, Yu Tao, Mark A. Watson, Rebecca Aft, Ryan C. Fields, William G. Hawkins, David G. DeNardo
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (8): 1055–1067.
https://doi.org/10.1158/2326-6066.CIR-21-0946
Published: 03 August 2023
View articletitled, Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer
Open the PDF for Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer

Free
Bhalchandra Mirlekar, Daniel Michaud, Samuel J. Lee, Nancy P. Kren, Cameron Harris, Kevin Greene, Emily C. Goldman, Gaorav P. Gupta, Ryan C. Fields, William G. Hawkins, David G. DeNardo, Naim U. Rashid, Jen Jen Yeh, Autumn J. McRee, Benjamin G. Vincent, Dario A.A. Vignali, Yuliya Pylayeva-Gupta
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2020) 8 (3): 292–308.
https://doi.org/10.1158/2326-6066.CIR-19-0349
Published: 02 March 2020
View articletitled, B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer
Open the PDF for B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B56: CXCR2 blockade reduces granulocytic myeloid cell compensation in response to macrophage targeted therapy and further enhances the efficacy of chemotherapy in pancreatic ductal adenocarcinoma

Free
Booyeon J. Han, Tim M. Nywening, Brian A. Belt, Jian Ye, William G. Hawkins, David G. DeNardo, David C. Linehan
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (9_Supplement): B56.
https://doi.org/10.1158/2326-6074.TUMIMM17-B56
Published: 01 September 2018
View articletitled, Abstract B56: CXCR2 blockade reduces granulocytic myeloid cell compensation in response to macrophage targeted therapy and further enhances the efficacy of chemotherapy in pancreatic ductal adenocarcinoma